Pure Global AI
NCT06385028Not yet recruiting

Physical Activity Promotion in Osteoarthritis Patients

Personalized Physical Activity Promotion in Osteoarthritis Patients Using a Smartphone-based Solution
Luxembourg Institute of HealthClinicalTrials.govbehavioral
Study focus
Disease/Condition
Osteoarthritis
Drug/Device/Intervention
Physical activity promotion
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Luxembourg Institute of Health
Location
Strassen, Luxembourg
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2024
End date
Dec 31, 2026
Enrollment
150 participants
Primary outcome

Weekly number of connections to the application over time,Response rate to the weekly questionnaires over time

Summary

The main purpose of this project is to promote physical activity in patients with
 osteoarthritis. More specifically, this study aims to test the acceptability of an app to
 promote physical activity in the target population, and consequently the feasibility of such
 an approach.
 
 A mobile phone application - namely PIANISSIMO - will be developed specifically for this
 project. It aims to spread knowledge on the benefits of physical activity and collect data on
 how this knowledge can induce behavior changes toward a more physically active lifestyle.
 
 The intervention is delivered via the app, which will send daily notifications on physical
 activity and sedentary behavior, and ask the participants to set their weekly goal (i.e.,
 daily steps). The app will also collect daily steps count and ask the participant to fill in
 questionnaire on pain once a week.

ICD-10 classifications
Other hypertrophic osteoarthropathyOther specified osteochondropathiesPolyarthritis, unspecifiedOther osteochondropathiesOsteochondritis dissecans
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06385028
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06385028 through Pure Global AI's free database. This phase not specified trial is sponsored by Luxembourg Institute of Health and is currently Not yet recruiting. The study focuses on Osteoarthritis. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.